Therapeutic potential of spirooxindoles as antiviral agents

Na Ye, Haiying Chen, Eric A. Wold, Pei Yong Shi, Jia Zhou

Research output: Contribution to journalReview articlepeer-review

350 Scopus citations


Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes for antiviral drug development. Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model. This review highlights recent advances in the development of biologically active spirooxindoles for their antiviral potential, primarily focusing on the structure-activity relationships (SARs) and modes of action, as well as future directions to achieve more potent analogues toward a viable antiviral therapy.

Original languageEnglish (US)
Pages (from-to)382-392
Number of pages11
JournalACS Infectious Diseases
Issue number6
StatePublished - Jun 10 2016


  • DENV
  • HIV
  • RSV
  • antiviral agents
  • influenza virus
  • spirooxindoles

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Therapeutic potential of spirooxindoles as antiviral agents'. Together they form a unique fingerprint.

Cite this